The Study of Reducing Adverse Effects After Radiofrequency Ablation Combined With Sclerotherapy
Status:
Not yet recruiting
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether adding sulodexide to the patients with
varicose veins who received radiofrequency ablation combined with sclerotherapy can reduce or
improve the impact of adverse events。
Phase:
N/A
Details
Lead Sponsor:
Chengdu University of Traditional Chinese Medicine